FDA Deputy Commissioner Details Agency’s Priorities In Recent Speech


In This Issue:

- Snapshot of the Agency: FDA-regulated products

- Recent Public Health Milestones

- Innovative Programs at FDA

..A. FDA has a number of programs intended to speed the availability of promising new therapies to patents with serious and life-threatening illnesses.

..B. Pediatric & Rare Disease Initiatives

..C. Drug, Biologics & Device Innovation

..D. Advancements in Clinical Trials

- Cross-FDA Alignment Initiatives

- Policy Initiatives Underway

- Excerpt from Snapshot of the Agency: FDA-regulated products:

Products Regulated by FDA Include:

- Human Drugs

- Rx, OTC, Generics

- Vaccines, Blood Products, and Other Biologics

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Affordable Care Act, Approval, Clinical Trials, FDA, Food Safety, Generic Drugs, Healthcare, Healthcare Reform, Medical Devices, New Regulations, Prescription Drugs, Proposed Regulation, Veterinary Products

Published In: General Business Updates, Health Updates, Privacy Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Polsinelli | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »